Literature DB >> 31943442

A thymic stromal lymphopoietin polymorphism may provide protection from asthma by altering gene expression.

Amy Moorehead1, Raphael Hanna1, Delia Heroux1, Helen Neighbour1, Andrew Sandford2, Gail M Gauvreau1, Doron D Sommer3, Judah A Denburg1, Loubna Akhabir1.   

Abstract

BACKGROUND: Genome-wide association studies have identified associations of the single nucleotide polymorphism rs1837253 in the thymic stromal lymphopoietin (TSLP) gene with asthma, allergic disease and eosinophilia. The TSLP gene encodes two isoforms, long and short, and previous studies have indicated functional differences between these two isoforms.
OBJECTIVE: We investigated the expression of these TSLP isoforms in response to a pro-inflammatory signal, and the role of the rs1837253 genotype in gene isoform regulation.
METHODS: We cultured nasal epithelial cells of asthmatic and non-asthmatic subjects and evaluated poly(I:C)-induced TSLP protein secretion using multiplex protein assays and gene expression profiles of the TSLP isoforms, and related genes using real-time qPCR. We correlated these profiles with rs1837253 genotype.
RESULTS: Asthmatic nasal epithelial cells exhibited increased TSLP protein secretion compared with nasal epithelial cells from healthy controls. The long TSLP isoform was more responsive to poly(I:C) stimulation. Additionally, the minor T allele of rs1837253 was less inducible than the major C allele, suggesting differential regulation; this may explain the "protective" effects of the T allele in asthma.
CONCLUSION: Our results provide important insights into the differential regulation and function of TSLP isoforms, including the role of TSLP rs1837253 polymorphisms in allergic inflammatory processes. CLINICAL RELEVANCE: The key finding on the influence of TSLP genetic variation on disease expression/endotype could provide basis for investigation into targeted biologics for anti-TSLP therapies.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  SNP; TSLP; asthma; isoforms; nasal epithelium; rs1837253

Mesh:

Substances:

Year:  2020        PMID: 31943442     DOI: 10.1111/cea.13568

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  9 in total

Review 1.  Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions.

Authors:  Remo Poto; Stefania Loffredo; Francesco Palestra; Gianni Marone; Vincenzo Patella; Gilda Varricchi
Journal:  Cells       Date:  2022-05-23       Impact factor: 7.666

Review 2.  Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP).

Authors:  Ludger Klimek; Jan Hagemann; Hans-Jürgen Welkoborsky; Mandy Cuevas; Ingrid Casper; Ulrike Förster-Ruhrmann; Felix Klimek; Constantin A Hintschich; Tilman Huppertz; Christoph Bergmann; Peter-Valentin Tomazic; Sven Becker
Journal:  Allergol Select       Date:  2022-04-29

Review 3.  Targeting TSLP in Asthma.

Authors:  Jane R Parnes; Nestor A Molfino; Gene Colice; Ubaldo Martin; Jonathan Corren; Andrew Menzies-Gow
Journal:  J Asthma Allergy       Date:  2022-06-03

Review 4.  Neutrophils and Asthma.

Authors:  Akira Yamasaki; Ryota Okazaki; Tomoya Harada
Journal:  Diagnostics (Basel)       Date:  2022-05-08

Review 5.  Sex Plays a Multifaceted Role in Asthma Pathogenesis.

Authors:  Tomomitsu Miyasaka; Kaori Dobashi-Okuyama; Kaori Kawakami; Chiaki Masuda-Suzuki; Motoaki Takayanagi; Isao Ohno
Journal:  Biomolecules       Date:  2022-04-29

6.  Association between functional genetic variants in retinoid X receptor-α/γ and the risk of gestational diabetes mellitus in a southern Chinese population.

Authors:  Xiang-Yuan Yu; Li-Ping Song; Hui-Ting Zheng; Shu-Dan Wei; Xiao-Lan Wen; Bo Huang; Da-Bin Liu
Journal:  Biosci Rep       Date:  2021-10-29       Impact factor: 3.840

Review 7.  TLR Signals in Epithelial Cells in the Nasal Cavity and Paranasal Sinuses.

Authors:  Masanobu Suzuki; Clare Cooksley; Takayoshi Suzuki; Mahnaz Ramezanpour; Akira Nakazono; Yuji Nakamaru; Akihiro Homma; Sarah Vreugde
Journal:  Front Allergy       Date:  2021-11-22

Review 8.  Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?

Authors:  Andrew Menzies-Gow; Michael E Wechsler; Chris E Brightling
Journal:  Respir Res       Date:  2020-10-15

9.  Asthma management and impact on COVID-19 outcomes.

Authors:  Robert J Boyle; Mohamed H Shamji
Journal:  Clin Exp Allergy       Date:  2021-09       Impact factor: 5.018

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.